drugs

US Senators Seek Answers on Drug Shortages

In what is being billed as a bipartisan effort to address shortages along the US pharmaceutical supply chain, two senators — one Democrat, one Republican — have introduced legislation that calls for an investigation of the problems and development of a plan to reduce the country’s dependence on imported drugs.

Gingko Enters Dyes and Drugs Partnerships

US biology company Ginkgo Bioworks has announced two separate partnerships, one on natural colors and dyes with Octarine Bio and the other on novel therapeutic molecules with drugmaker Boehringer Ingelheim.

New US Law Spells Changes for Drugs and Emissions

Both houses of the US Congress have passed the White House’s $430 billion bill, which could decisively shape issues as diverse as pharmaceutical pricing and greenhouse gas emissions.

Supply Chain Integrity and Patient Safety

New Rules For Pharma

J&J Protests Death Row Use of its Drug

Death Penalty Drugs Under Scrutiny Again

UK Said Cutting Costs for Expensive Drugs

Value of Pharma M&A Doubled in 2016

Texas Sues FDA Over Execution Drug Shipment

US House Passes Medical R&D Funding Bill

US Legislator Challenges Drugmakers on Lethal Injections

The Art of the Alliance

After Pharma’s Patent Cliff

Ackman Trims Valeant Stake to Create Tax Benefits

EU Approves Pfizer-Hospira Deal With Strings

Bristol-Myers Squibb HIV Drug Fast-Tracked

Fenofibrate May Be Substitute for Medical Marijuana

EU Agency Lifts Lid on Drug Data Secrets

Toxic Capsules Help the Medicine Go down in China